APP and Alzheimer disease: In treating AD, a possible therapeutic strategy is reducing Aβ levels in the brain which can be achieved by inhibiting the generation of Aβ by targeting APP or secretases, triggering mechanisms that clear Aβ species, or developing mechanisms that balance production and clearance of Aβ peptide in the brain [35].